Company Update
Life has more to give.
We help biology perform better. Across agriculture and human health, our technologies address practical constraints that can limit crop productivity, molecule formulation and effective delivery.
Agriculture
Grow With Agrarius™
Biological plant-signaling technology designed to support crop productivity, resilience and more efficient use of available inputs.
For growers, distributors and agricultural partners seeking measurable performance under real-world growing conditions.
Explore Agrarius™Human Health
Two patented technologies addressing fundamental barriers in molecule formulation and delivery.
Quicksome™
Sublingual formulation and delivery technology for selected molecules limited by oral degradation, inconsistent absorption, injection or cold-chain requirements.
Quicksol™
Solubility formulation technology for selected molecules limited by poor aqueous solubility.
For formulators, compound pharmacies, manufacturers and commercial partners seeking differentiated delivery and formulation solutions.
Explore Human Health
The latest from the newsroom.
Press releases, company updates and coverage from across our human health and agriculture platforms.
Company UpdateQuicksome™: Building The Commercial Pathway
MLCO enters a strategic LOI with a U.S. 503A compounding pharmacy for Quicksome
- (opens in a new tab)
Press ReleaseThe More Life Company Advancing US Compounded Pharmaceutical Commercialization Pathway for Quicksome™
Strategic LOI advances U.S. compounding capability for a growing portfolio of potential Quicksome-enabled pharmaceutical applications
Company UpdateQuicksome™: A Step Forward in Needle-Free Hormone Delivery
This morning we announced results from our exploratory human Quicksome™ testosterone study, and I am pleased to share why I believe this work represents an important step for the Company.
- (opens in a new tab)
Press ReleaseMLCO. Reports Rapid Systemic Delivery of USP Testosterone in Exploratory Quicksome™ Study
Eight-participant pharmacokinetic study shows rapid systemic appearance following administration of 5 mg and 15 mg Quicksome™ sublingual formulations
Company UpdateMore Life In The Field
Up to 32.5% more special-grade yield and 27.6% more total yield versus control. The independently designed and conducted Brazilian trial showed the strongest Agrarius program adding 8.0 tonnes per hectare in the higher-value 45 to 70 mm category, lifting special-grade share to about 80.7% of total yield versus 76.4% in the control.
- (opens in a new tab)
Press ReleaseMLCO Reports Positive Third-Party Agrarius Potato Trial Results in Brazil
Independent randomized field trial recorded numerical increases of up to 32.5% in special-grade potato yield and up to 27.6% in total yield in the leading Agrarius application programs.
- (opens in a new tab)
Press ReleaseThe More Life Company Announces New USA Trading Symbol
The More Life Company (formerly MVMD), announces the completion of its corporate name change and is pleased to announce that its common shares will continue to be quoted on the OTCID under the new trading symbol “TMLCF”.
Company UpdateIntroducing The More Life Company
This morning, we announced the completion of our corporate name change from Mountain Valley MD to The More Life Company.
- (opens in a new tab)
Press ReleaseThe More Life Company Announces Completion of Name Change From Mountain Valley MD
The More Life Company, formerly Mountain Valley MD Holdings Inc. (CSE: MVMD) (OTC: MVMDF), is pleased to announce that it has completed a corporate name change.
Company UpdateMVMD Shareholder Update: Strengthening the Team for Our Next Phase
This morning we announced the appointment of five additional advisors to MVMD,
- (opens in a new tab)
Press ReleaseMVMD Announces Appointment of Additional Advisors and Stock Option Grants
The Company has appointed the five individuals listed below as advisors to provide strategic advisory services to the Company.